Urolift – minimally invasive surgical BPH management

Abstract

An ideal treatment option for symptomatic Benign Prostatic Hyperplasia (BPH) should relieve lower urinary tract symptoms (LUTS) and restore Quality of Life (QoL). Currently available medical therapies and surgical options for symptomatic BPH have side effects that adversely affects quality of life. Prostatic urethral lift (PUL) is a novel endourology procedure that promises to relieve LUTS without the aforementioned side effects. Areas covered: We diligently reviewed all the published literature on PUL, till July 2016 using standard search criteria. Expert commentary: There is good quality evidence to establish the efficiency of PUL in treating symptomatic BPH without adversely affecting the QoL. Based on the current literature, PUL can be considered as an option for those symptomatic BPH patients with small or medium size prostates (< 80 ml) without median lobe enlargement, who failed on medical therapy or are intolerant to it and wish to preserve their sexual function.

Low power HOLEP after failed urolift: A case report using 50 Watt laser

“…The UroLift device was recently introduced as a means to perform prostatic urethral lift procedure for lateral lobe hypertrophy in patients with obstructive voiding symptoms, who would like to avoid sexual and ejaculatory dysfunction. 1 Crucially, Urolift has been associated with a failure rate of 7% at 2 years and 14% at 4 years, 2 and with the increasing popularity of the Urolift procedure, urologists should be prepared to perform secondary procedures in cases of Urolift failure. Whilst high power 100W HOLEP has been performed, 3 in this case report, we describe the first use of low power HOLEP using 50 Watt Laser in a case of failed Urolift implantation.…”

A Systematic Review and Meta-analysis of Prostatic Urethral Lift for Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

“…The average improvement of IPSS was 10.45 (−11.70, −9.20) and 9.73 (−10.77, −8.69) points at 12- and 24-mo follow-ups, respectively. PUL has a similar effect on symptom relief to other minimally invasive treatments (TUNA and TUMT) [1] , [16] , [37] , [38] and is superior to medical therapies and placebo [37] . In addition, the relatively stable improvement of IPSS by PUL can last throughout 24 mo of follow-up.…”

Review and update of benign prostatic hyperplasia in general practice

“…28 The prostatic urethral lift is usually unsuitable for men with urinary retention, obstructing median lobes or prostates >80 mL. 29…”